Subscribe To
Johnson & johnson quietly halted production of its covid-19 vaccines: nyt
The Times reported that the company shut down the only plant making usable vaccine batches in the Nethe...
February 8, 2022, 11:18 am
Johnson & johnson quietly halted production of its covid-19 vaccines: nyt
The Times reported that the company shut down the only plant making usable vaccine batches in the Nethe...
February 8, 2022, 11:18 am
J&j pauses production of its covid-19 vaccine - nyt
(Reuters) -Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 v...
February 8, 2022, 11:12 am
J&j pauses production of its covid-19 vaccine - nyt
(Reuters) -Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 v...
February 8, 2022, 11:12 am
J&j pauses production of its covid-19 vaccine - nyt
(Reuters) -Johnson & Johnson late last year quietly shut down the only plant making usable batches of its COVID-19 v...
February 8, 2022, 11:12 am
Pfizer triggers $28 billion stock plunge after warning covid vaccine sales may disappoint this year
Despite nabbing $12.5 billion in Covid vaccine sales last year, Pfizer stock plunged as much as 6% Tues...
February 8, 2022, 10:49 am
Pfizer triggers $28 billion stock plunge after warning covid vaccine sales may disappoint this year
Despite nabbing $12.5 billion in Covid vaccine sales last year, Pfizer stock plunged as much as 6% Tues...
February 8, 2022, 10:49 am
Pfizer triggers $28 billion stock plunge after warning covid vaccine sales may disappoint this year
Despite nabbing $12.5 billion in Covid vaccine sales last year, Pfizer stock plunged as much as 6% Tues...
February 8, 2022, 10:49 am
Novavax stock sinks as vaccine deliveries fall short
Novavax, Inc (NASDAQ:NVAX) is plummeting this morning, down 14% to trade at $81.56 at last check, on news that the company has only delivered 10 mill...
February 8, 2022, 10:38 am
Novavax stock sinks as vaccine deliveries fall short
Novavax, Inc (NASDAQ:NVAX) is plummeting this morning, down 14% to trade at $81.56 at last check, on news that the company has only delivered 10 mill...
February 8, 2022, 10:38 am
Novavax stock sinks as vaccine deliveries fall short
Novavax, Inc (NASDAQ:NVAX) is plummeting this morning, down 14% to trade at $81.56 at last check, on news that the company has only delivered 10 mill...
February 8, 2022, 10:38 am
Pfizer drops after issuing weaker 2022 outlook, dragging covid-19 vaccine makers moderna and novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expectations of $104 billion....
February 8, 2022, 9:34 am
Pfizer drops after issuing weaker 2022 outlook, dragging covid-19 vaccine makers moderna and novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expectations of $104 billion....
February 8, 2022, 9:34 am
Pfizer drops after issuing weaker 2022 outlook, dragging covid-19 vaccine makers moderna and novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expectations of $104 billion....
February 8, 2022, 9:34 am
Moderna: will omicron-specific vaccine bolster stock forecast?
Moderna announced its study for an Omicron-specific vaccine in response to the variant's rapid ascenden...
February 8, 2022, 8:45 am
Moderna: will omicron-specific vaccine bolster stock forecast?
Moderna announced its study for an Omicron-specific vaccine in response to the variant's rapid ascenden...
February 8, 2022, 8:45 am
Moderna: will omicron-specific vaccine bolster stock forecast?
Moderna announced its study for an Omicron-specific vaccine in response to the variant's rapid ascenden...
February 8, 2022, 8:45 am
Pfizer's balance sheet is 'bulletproof' thanks to covid vaccine, says dcla's sethi
Sarat Sethi, managing partner and portfolio manager at DCLA, joins CNBC's 'Squawk Box' to break down shares of Pfizer following the company's latest f...
February 8, 2022, 8:44 am
Pfizer's balance sheet is 'bulletproof' thanks to covid vaccine, says dcla's sethi
Sarat Sethi, managing partner and portfolio manager at DCLA, joins CNBC's 'Squawk Box' to break down shares of Pfizer following the company's latest f...
February 8, 2022, 8:44 am
Pfizer's balance sheet is 'bulletproof' thanks to covid vaccine, says dcla's sethi
Sarat Sethi, managing partner and portfolio manager at DCLA, joins CNBC's 'Squawk Box' to break down shares of Pfizer following the company's latest f...
February 8, 2022, 8:44 am